# Metropolitan Bank Holding Corp. (MCB)

Informational only - not investment advice.

CIK: 0001476034
SIC: 6022 State Commercial Banks
SIC breadcrumb: [Finance, Insurance, And Real Estate](/division/H/) > [Depository Institutions](/major-group/60/) > [SIC 6022 State Commercial Banks](/industry/6022/)
Latest 10-K filed: 2026-02-20
SEC page: https://www.sec.gov/edgar/browse/?CIK=1476034
Filing source: https://www.sec.gov/Archives/edgar/data/1476034/000110465926018208/mcb-20251231x10k.htm

## At a glance

FY2025 · period end 2025-12-31 · filed 2026-02-20 · accession 0001104659-26-018208 · source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001476034.json

| Metric | Value | FY | Provenance |
| --- | ---: | ---: | --- |
| Revenue | 515,278,000 USD | 2025 | verified |
| Net income | 71,098,000 USD | 2025 | verified |
| Assets | 8,255,716,000 USD | 2025 | verified |
| Net margin | 13.80% | 2025 | computed |
| Revenue YoY | +10.01% | 2025 | computed |
| ROE | 9.57% | 2025 | computed |

Computed values are grepcent-computed from the verified facts above and may differ from ratios the company itself reports. Net margin = net income ÷ revenue. Revenue YoY = FY2025 revenue ÷ FY2024 revenue − 1 (consecutive fiscal years only). ROE = net income ÷ period-end stockholders' equity.

No market price, no rating, no forecast on this site. Not investment advice.

### Peer percentile fingerprint

| Ratio | MCB | Peer median | Percentile | N |
| --- | ---: | ---: | ---: | ---: |
| Net margin | 13.8% | 21.9% | 16 | 149 |
| Revenue growth | 10.0% | 6.0% | 71 | 148 |
| ROE | 9.6% | 9.6% | 45 | 149 |
| ROA | 0.9% | 1.1% | 31 | 149 |
| Liabilities / equity | 10.11 | 8.04 | 84 | 149 |

Percentile = share of the N covered peers reporting that ratio whose value is lower (ties counted half); computed among grepcent-covered companies in SIC industry 6022 State Commercial Banks, not the whole market. A higher percentile means a higher value of the ratio, not a better company. Ratios with fewer than 8 reporting peers are omitted. Latest reported values per company; fiscal periods may differ. Descriptive arithmetic - not a score, rating, or ranking.

## Selected Fundamentals
| Metric | Value | Unit | FY | Filed |
| --- | ---: | --- | ---: | --- |
| Revenue | 515278000 | USD | 2025 | 2026-02-20 |
| Net income | 71098000 | USD | 2025 | 2026-02-20 |
| Assets | 8255716000 | USD | 2025 | 2026-02-20 |

## Financials

Annual standardized facts from SEC companyfacts as of latest extracted filing date 2026-02-20. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001476034.json. Derived margins, ratios, and free cash flow are computed from the extracted annual SEC facts.

| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | 44,155,000 | 60,864,000 | 83,945,000 | 129,780,000 | 143,097,000 | 173,284,000 | 260,739,000 | 375,405,000 | 468,379,000 | 515,278,000 |
| Net income | 5,013,000 | 12,369,000 | 25,554,000 | 30,134,000 | 39,466,000 | 60,555,000 | 59,425,000 | 77,268,000 | 66,686,000 | 71,098,000 |
| Diluted EPS | 0.43 | 2.34 | 3.06 | 3.56 | 4.66 | 6.45 | 5.29 | 6.91 | 5.93 | 6.62 |
| Operating cash flow | 14,558,000 | 31,473,000 | 27,060,000 | 38,956,000 | 87,270,000 | 37,277,000 | 85,891,000 | 42,426,000 | 148,459,000 | 88,680,000 |
| Dividends paid |  |  |  |  |  |  |  |  |  | 3,120,000 |
| Share buybacks |  | 255,000 |  |  |  |  |  |  |  | 73,466,000 |
| Assets | 1,220,301,000 | 1,759,855,000 | 2,182,644,000 | 3,357,572,000 | 4,330,821,000 | 7,116,358,000 | 6,267,337,000 | 7,067,672,000 | 7,300,749,000 | 8,255,716,000 |
| Liabilities | 1,110,810,000 | 1,522,971,000 | 1,918,127,000 | 3,058,448,000 | 3,990,034,000 | 6,559,369,000 | 5,691,440,000 | 6,408,651,000 | 6,570,922,000 | 7,512,604,000 |
| Stockholders' equity | 109,491,000 | 236,884,000 | 264,400,000 | 299,124,000 | 340,787,000 | 556,989,000 | 575,897,000 | 659,021,000 | 729,827,000 | 743,112,000 |
| Cash and cash equivalents | 82,931,000 | 261,231,000 | 232,950,000 | 389,220,000 | 864,305,000 | 2,359,350,000 | 257,418,000 | 269,465,000 | 200,268,000 | 393,587,000 |

### Ratios

ROE and ROA use period-end equity/assets. Liabilities / equity uses total liabilities divided by stockholders' equity. Current ratio uses current assets divided by current liabilities when both are reported.

| Metric | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Net margin | 11.35% | 20.32% | 30.44% | 23.22% | 27.58% | 34.95% | 22.79% | 20.58% | 14.24% | 13.80% |
| Return on equity | 4.58% | 5.22% | 9.66% | 10.07% | 11.58% | 10.87% | 10.32% | 11.72% | 9.14% | 9.57% |
| Return on assets | 0.41% | 0.70% | 1.17% | 0.90% | 0.91% | 0.85% | 0.95% | 1.09% | 0.91% | 0.86% |
| Liabilities / equity | 10.15 | 6.43 | 7.25 | 10.22 | 11.71 | 11.78 | 9.88 | 9.72 | 9.00 | 10.11 |

## As-reported value updates

2 tracked differences above grepcent's stated thresholds were found between the earliest XBRL-filed value and the value currently on file for the same fiscal period.

Ledger: /company/MCB/revisions/


## Quarterly

Quarterly standardized facts from SEC companyfacts as of latest extracted filing date 2026-07-31. Source: https://data.sec.gov/api/xbrl/companyfacts/CIK0001476034.json.

Flow metrics use discrete quarter-length periods from 10-Q/10-Q/A filings. Q4 revenue and net income are derived only when annual FY and nine-month YTD facts exist for the same fiscal year; derived Q4 values are labeled. EPS Q4 is not derived.

| Quarter | End date | Revenue | Net income | Diluted EPS | Method |
| --- | --- | ---: | ---: | ---: | --- |
| 2022-Q3 | 2022-09-30 |  |  | 2.23 | reported discrete quarter |
| 2023-Q1 | 2023-03-31 |  |  | 2.25 | reported discrete quarter |
| 2023-Q2 | 2023-06-30 |  |  | 1.37 | reported discrete quarter |
| 2023-Q3 | 2023-09-30 | 97,897,000 | 22,063,000 | 1.97 | reported discrete quarter |
| 2023-Q4 | 2023-12-31 | 105,267,000 | 14,568,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2024-Q1 | 2024-03-31 | 112,335,000 | 16,203,000 | 1.46 | reported discrete quarter |
| 2024-Q2 | 2024-06-30 | 115,761,000 | 16,799,000 | 1.50 | reported discrete quarter |
| 2024-Q3 | 2024-09-30 | 120,454,000 | 12,266,000 | 1.08 | reported discrete quarter |
| 2024-Q4 | 2024-12-31 | 119,829,000 | 21,418,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2025-Q1 | 2025-03-31 | 118,770,000 | 16,354,000 | 1.45 | reported discrete quarter |
| 2025-Q2 | 2025-06-30 | 127,043,000 | 18,767,000 | 1.76 | reported discrete quarter |
| 2025-Q3 | 2025-09-30 | 132,000,000 | 7,119,000 | 0.67 | reported discrete quarter |
| 2025-Q4 | 2025-12-31 | 137,465,000 | 28,858,000 |  | derived Q4 = FY annual - nine-month YTD |
| 2026-Q1 | 2026-03-31 | 134,932,000 | 31,426,000 | 2.92 | reported discrete quarter |
| 2026-Q2 | 2026-06-30 | 140,938,000 | 19,223,000 | 1.54 | reported discrete quarter |

## Filed narrative (10-K & 10-Q)

## Business

Verbatim Item 1 Business section from MCB's latest 10-K: [/company/MCB/business/](/company/MCB/business/).

## Risk Factors

Verbatim Item 1A Risk Factors from MCB's latest 10-K: [/company/MCB/risk-factors/](/company/MCB/risk-factors/).

## Latest quarter (10-Q)

Latest 10-Q source: https://www.sec.gov/Archives/edgar/data/1476034/000110465926089011/mcb-20260630x10q.htm

Extracted structurally from real Item 2 body heading to real Item 3/4 boundary.
Confidence: high
Filing date: 2026-07-31
Report date: 2026-06-30

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Company Background

The Company is a bank holding company headquartered in New York, New York and registered under the BHC Act. Through its wholly owned bank subsidiary, Metropolitan Commercial Bank, a New York state-chartered commercial bank, the Company provides a broad range of business, commercial and retail banking products and services to small businesses, middle-market enterprises, public entities and individuals primarily in the New York metropolitan area. See the “GLOSSARY OF COMMON TERMS AND ACRONYMS” for the definition of certain terms and acronyms used throughout this Form 10-Q.

The Company’s primary lending products are CRE, including multi-family loans, and C&I loans. Substantially all loans are secured by specific items of collateral including business and consumer assets, and commercial and residential real estate. Commercial loans are expected to be repaid from cash flows from operations of commercial enterprises. The Company has developed various deposit gathering strategies, which generate the funding necessary to operate without a large branch network. In addition to traditional commercial banking products, the Company offers: corporate cash management and retail banking services; tailored financial solutions for government entities, municipalities, and public institutions; specialized services to facilitate secure and efficient real estate transactions and tax-deferred exchanges for title and escrow and Section 1031 exchanges; and EB-5 Program escrow accounts of foreign investor funds for USCIS approved job-creating projects. The Company’s primary deposit products are checking, savings, and term deposit accounts, all of which are insured by the FDIC up to the maximum amounts allowed by law. These activities, together with eight strategically located banking centers, generate a stable source of deposits to support the growth of our diverse loan portfolio and other assets.

The Company is focused on organically growing its position in the New York metropolitan area. Growth in other markets across the country is generally dependent on the business activities of our New York-based customers. Through an experienced team of commercial relationship managers and its integrated, client-centric approach, the Company has grown market share by deepening existing client relationships and continually expanding its client base through referrals and the ability to offer alternatives to traditional retail banking products. The Company has converted many of its commercial lending clients into full retail relationship banking clients. Given the size of the market in which the Company operates and its differentiated approach to client service, there is significant opportunity to further grow its loans and deposits. By combining high-tech service with the relationship-based focus of a community bank with an extensive suite of financial products and services, the Company is well-positioned to continue to capitalize on the significant growth opportunities available in the New York metropolitan area and elsewhere. 

Recent Events

On June 6, 2026, William Reinhardt retired from the Board of Directors and the board of directors of the Bank.

​

On June 19, 2026, the Board of Directors of the Company approved a new share repurchase program pursuant to which the Company is authorized to repurchase up to $50.0 million of its outstanding common stock, par value $0.01 per share (the “Share Repurchase Program”). Repurchases under the Share Repurchase Program may be conducted from time to time on the open market or by other means in accordance with applicable securities laws and other restrictions, including, in part, under a Rule 10b5-1 plan, which allows stock repurchases when the Company might otherwise be precluded from doing so. The number of shares to be repurchased and the timing of repurchases, if any, will depend on several factors, including market conditions, prevailing share price, corporate and regulatory requirements, and other considerations.

​

The Share Repurchase Program represents a newly authorized program that replaces and supersedes the previously disclosed program that was authorized by the Company’s Board of Directors on July 17, 2025.

​

The Company intends to fund the Share Repurchase Program with available cash. The Share Repurchase Program has no expiration date, may be discontinued or suspended at any time and does not obligate the Company to acquire any amount of its common stock. The Company records the purchase of treasury stock at cost.

35

Table of Contents

Critical Accounting Policies

Critical accounting estimates are necessary in the application of certain accounting policies and procedures and are particularly susceptible to significant change. Critical accounting policies are defined as those involving significant judgments and assumptions by management that could have a material impact on the carrying value of certain assets or on income under different assumptions or conditions. Management believes the Company’s most critical accounting policy, which involves the most complex or subjective decisions or assessments, is the allowance for credit losses.

Allowance for Credit Losses

The ACL has been determined in accordance with GAAP. The Company is responsible for the timely and periodic determination of the amount of the ACL. Management believes that the ACL for loans and loan commitments is adequate to cover expected credit losses over the life of the loan portfolio. Although management evaluates available information to determine the adequacy of the ACL, the level of allowance is an estimate which is subject to significant judgment and short-term change. Because of uncertainties associated with local and national economic forecasts, the operating and regulatory environment, collateral values and future cash flows from the loan portfolio, it is possible that a material change could occur in the ACL. The evaluation of the adequacy of loan collateral is often based upon estimates and appraisals. Because of uncertain economic conditions, the valuations determined from such estimates and appraisals may change. Accordingly, the Company may ultimately incur losses that vary from management’s current estimates. Adjustments to the ACL will be reported in the period in which such adjustments become apparent and can be reasonably estimated. All loan losses are charged-off to the ACL when the loss actually occurs or when the collectability of principal is deemed to be unlikely. Recoveries are credited to the allowance at the time of recovery. Various regulatory agencies, as an integral part of their examination process, periodically review the Company’s ACL. As a result of such examinations, the Company may need to recognize additions to the ACL based on the regulators’ observations.

In estimating the ACL, the Company relies on models and economic forecasts developed by external parties as the primary driver of the ACL. These external models and forecasts are based on nationwide data sets. Economic forecasts can change significantly over an economic cycle and have a significant level of uncertainty associated with them. The performance of these models is dependent on the variables used in the models being reasonable predictors for the loan portfolio’s performance. However, these variables may not capture all sources of risk within the portfolio. As a result, the Company reviews the results and makes qualitative adjustments to capture potential limitations of the external models as necessary. Such qualitative factors may include adjustments to better capture the imprecision associated with the economic forecasts, and the ability of the models to capture emerging risks within the portfolio that may not be represented in the data. These adjustments are evaluated through the Company’s review process and revised on a quarterly basis to account for changes in forecasts, facts and circumstances.

The measurement of all expected credit losses for financial assets held at amortized cost is based on historical experience, current conditions, and reasonable and supportable forecasts. The Company continuously monitors current conditions and events and will evaluate potential changes that will enhance the estimation process. During the quarter ended March 31, 2026, the peer group selection process, macroeconomic forecast weightings, and the qualitative factor process were adjusted to reflect current conditions and events. The Company accounted for these revisions prospectively as a change in accounting estimate beginning March 31, 2026, and no prior period amounts were adjusted. The effect of this change in accounting estimate for the three months ended March 31, 2026, was a net decrease in the provision for credit losses of $6.4 million, which is $4.6 million, net of tax, or $0.43 per basic earnings per share and $0.42 per dilutive earnings per share.

One of the more significant judgments involved in estimating the Company’s ACL relates to the macroeconomic forecasts used to estimate credit losses and the relative weightings applied to them. To illustrate the impact of changes in these forecasts to the Company’s ACL, the Company performed a hypothetical sensitivity analysis that decreased the weight on the baseline scenario by 33% and equally allocated the difference to increase the weighting on the more optimistic and adverse scenarios. All else equal, the impact of this hypothetical forecast would result in a net increase of approximately $2.5 million, or 4.0%, in the Company’s total ACL for loans and loan commitments as of June 30, 2026. This hypothetical analysis is intended to illustrate the impact of adverse changes in the macroeconomic forecasts at a point in time and is not intended to reflect the full nature and extent of potential future change in the ACL. It is difficult to estimate how potential

36

Table of Contents

changes in any one of the quantitative inputs or qualitative factors might affect the overall ACL and the Company’s current assessments may not reflect the potential future impact of changes to those inputs or factors.

Discussion of Financial Condition

The Company had total assets of $8.9 billion at June 30, 2026, an increase of $603.0 million, or 7.3%, from December 31, 2025. Total cash and cash equivalents were $239.3 million at June 30, 2026, as compared to $393.6 million at December 31, 2025.

Investments

Total securities were $1.1 billion at June 30, 2026, an increase of $147.3 million or 15.7%, from December 31, 2025. The increase was primarily due to the purchase of $230.7 million of AFS and HTM securities, partially offset by the $76.7 million paydown and maturities of AFS and HTM securities.

Loans

Total loans, net of deferred fees and unamortized costs, were $7.3 billion at June 30, 2026, an increase of $518.7 million, or 7.6%, from December 31, 2025. The increase in total loans from December 31, 2025 was due primarily to an increase of $563.4 million in CRE loans (including owner-occupied). At June 30, 2026, 73.2% of the CRE and C&I loan portfolio was concentrated in the New York metropolitan area, mainly New York City, and Florida.

​

37

Table of Contents

As of June 30, 2026, total loans consisted primarily of CRE loans (including multi-family mortgage loans) and C&I loans. The Company’s commercial loan portfolio includes loans to the following industries (dollars in thousands)

[Excerpt truncated for page length; source filing is linked above.]

## Latest 10-K MD&A (excerpt)

Latest 10-K Item 7 source: https://www.sec.gov/Archives/edgar/data/1476034/000110465926018208/mcb-20251231x10k.htm
Complete FY 2025 MD&A: /company/MCB/mda/fy2025/

Extracted from a substantive MD&A body after the formal Item 7 span was a TOC or reference stub.
Confidence: high
Filing date: 2026-02-20
Report date: 2025-12-31

Executive Summary

The Company is a bank holding company headquartered in New York, New York and registered under the BHC Act. Through its wholly owned bank subsidiary, Metropolitan Commercial Bank, a New York state chartered commercial bank, the Company provides a broad range of business, commercial and retail banking products and services to small businesses, middle-market enterprises, public entities and individuals primarily in the New York metropolitan area. For an analysis of 2024 results compared with 2023 results, see Part II, Item 7., “Management's Discussion and Analysis of Financial Condition and Results of Operations” in the annual report on Form 10-K for the year ended December 31, 2024 filed with the SEC.

The Company’s primary lending products are CRE, including multi-family loans, and C&I loans. Substantially all loans are secured by specific items of collateral including business and consumer assets, and commercial and residential real estate. Commercial loans are expected to be repaid from cash flows from operations of commercial enterprises. The Company has developed various deposit gathering strategies, which generate the funding necessary to operate without a large branch network. In addition to traditional commercial banking products, the Company offers: corporate cash management and retail banking services; tailored financial solutions for government entities, municipalities, and public institutions; specialized services to facilitate secure and efficient real estate transactions and tax-deferred exchanges for title and escrow and Section 1031 exchanges; and EB-5 Program escrow accounts of foreign investor funds for USCIS approved job-creating projects. The Company’s primary deposit products are checking, savings, and term deposit accounts, all of which are insured by the FDIC up to the maximum amounts allowed by law. These activities, together with seven strategically located banking centers, generate a stable source of deposits to support the growth of our diverse loan portfolio and other assets.

The Company is focused on organically growing its position in the New York metropolitan area. Growth in other markets across the country is generally dependent on the business activities of our New York-based customers. Through an experienced team of commercial relationship managers and its integrated, client-centric approach, the Company has grown market share by deepening existing client relationships and continually expanding its client base through referrals and the ability to offer alternatives to traditional retail banking products. The Company has converted many of its commercial lending clients into full retail relationship banking clients. Given the size of the market in which the Company operates and its differentiated approach to client service, there is significant opportunity to further grow its loans and deposits. By combining high-tech service with the relationship-based focus of a community bank with an extensive suite of financial products and services, the Company is well-positioned to continue to capitalize on the significant growth opportunities available in the New York metropolitan area and elsewhere.

Critical Accounting Policies

A summary of accounting policies is provided in Note 2 to the consolidated financial statements included in this report. Critical accounting estimates are necessary in the application of certain accounting policies and procedures and are particularly susceptible to significant change. Critical accounting policies are defined as those involving significant judgments and assumptions by management that could have a material impact on the carrying value of certain assets or on income under different assumptions or conditions. Management believes the Company’s most critical accounting policy, which involves the most complex or subjective decisions or assessments, is the allowance for credit losses.

Allowance for Credit Losses

The ACL has been determined in accordance with GAAP. The Company is responsible for the timely and periodic determination of the amount of the ACL. Management believes that the ACL for loans and loan commitments is adequate to cover expected credit losses over the life of the loan portfolio. Although management evaluates available information to determine the adequacy of the ACL, the level of allowance is an estimate which is subject to significant judgment and short-term change. Because of uncertainties associated with local and national economic forecasts, the operating and

45

Table of Contents

regulatory environment, collateral values and future cash flows from the loan portfolio, it is possible that a material change could occur in the ACL. The evaluation of the adequacy of loan collateral is often based upon estimates and appraisals. Because of uncertain economic conditions, the valuations determined from such estimates and appraisals may change. Accordingly, the Company may ultimately incur losses that vary from management’s current estimates. Adjustments to the ACL will be reported in the period in which such adjustments become apparent and can be reasonably estimated. All loan losses are charged off to the ACL when the loss actually occurs or when the collectability of principal is deemed to be unlikely. Recoveries are credited to the allowance at the time of recovery. Various regulatory agencies, as an integral part of their examination process, periodically review the Company’s ACL. As a result of such examinations, the Company may need to recognize changes to the ACL based on the regulators’ observations.

In estimating the ACL, the Company relies on models and economic forecasts developed by external parties as the primary driver of the ACL. These external models and forecasts are based on nationwide data sets. Economic forecasts can change significantly over an economic cycle and have a significant level of uncertainty associated with them. The performance of these models is dependent on the variables used in the models being reasonable predictors for the loan portfolio’s performance. However, these variables may not capture all sources of risk within the portfolio. As a result, the Company reviews the results and makes qualitative adjustments to capture potential limitations of the external models as necessary. Such qualitative factors may include adjustments to better capture the imprecision associated with the economic forecasts, and the ability of the models to capture emerging risks within the portfolio that may not be represented in the data. These adjustments are evaluated through the Company’s review process and revised as necessary on a quarterly basis to account for changes in forecasts, facts and circumstances.

One of the more significant judgments involved in estimating the Company’s ACL relates to the macroeconomic forecasts used to estimate credit losses and the relative weightings applied to them. To illustrate the impact of changes in these forecasts to the Company’s ACL, the Company performed a hypothetical sensitivity analysis that decreased the weight on the baseline scenario by 33% and equally allocated the difference to increase the weights on the more optimistic and adverse scenarios. All else equal, the impact of this hypothetical forecast would result in a net increase of approximately $9.7 million, or 9.9%, in the Company’s total ACL for loans and loan commitments as of December 31, 2025. This hypothetical analysis is intended to illustrate the impact of changes in the macroeconomic forecasts at a point in time and is not intended to reflect the full nature and extent of potential future change in the ACL. It is difficult to estimate how potential changes in any one of the quantitative inputs or qualitative factors might affect the overall ACL and the Company’s current assessments may not reflect the potential future impact of changes to those inputs or factors. For further discussion of the ACL, see Part I, Item 1., “Business—Asset Quality—Allowance for Credit Losses—Loans and Loan Commitments.”

Recently Issued Accounting Standards

For a discussion of the impact of recently issued accounting standards, please see “NOTE 3 — SUMMARY OF RECENT ACCOUNTING PRONOUNCEMENTS” to the Company’s consolidated financial statements in this Form 10-K.

46

Table of Contents

Selected Financial Information

The following table includes selected financial information for the Company for the periods indicated:

[[GREPCENT_TABLE]]
[["\u200b","\u200b","\u200b","\u200b","\u200b","\u200b","\u200b","\u200b","\u200b","\u200b","\u200b","\u200b","\u200b"],["\u200b","\u200b","\u200b","At or for the year ended December 31,"],["\u200b","\u200b","\u200b","2025","\u200b \u200b \u200b","\u200b","\u200b","2024","\u200b","\u200b","\u200b \u200b \u200b","2023"],["Performance Ratios","\u200b","\u200b","\u200b","","\u200b","\u200b","\u200b","\u200b","\u200b","","\u200b","\u200b"],["Return on average assets","\u200b","\u200b","0.90","%","\u200b","\u200b","0.91","%","\u200b","\u200b","1.19","%"],["Return on average equity","\u200b","\u200b","9.70","","\u200b","\u200b","9.61","\u200b","\u200b","","12.44","\u200b"],["Net interest spread (1)","\u200b","\u200b","2.84","","\u200b","\u200b","1.94","\u200b","\u200b","","1.85","\u200b"],["Net interest margin (2)","\u200b","\u200b","3.88","","\u200b","\u200b","3.53","\u200b","\u200b","","3.49","\u200b"],["Average interest-earning assets to average interest-bearing liabilities","\u200b","\u200b","138.34","","\u200b","\u200b","152.84","\u200b","\u200b","","168.64","\u200b"],["Non-interest expense/average assets","\u200b","\u200b","2.23","","\u200b","\u200b","2.38","\u200b","\u200b","","2.02","\u200b"],["Efficiency ratio","\u200b","\u200b","55.86","","\u200b","\u200b","62.68","\u200b","\u200b","","52.46","\u200b"],["Average equity to average total assets","\u200b","\u200b","9.30","","\u200b","\u200b","9.52","\u200b","\u200b","","9.54","\u200b"],["\u200b","\u200b","\u200b","\u200b","\u200b","\u200b","\u200b","\u200b","\u200b","\u200b","\u200b","\u200b","\u200b"],["Earnings per Share","\u200b","\u200b","\u200b","","\u200b","\u200b","\u200b","\u200b","\u200b","","\u200b","\u200b"],["Basic earnings per common share","\u200b","$","6.71","\u200b","\u200b","$","5.97","\u200b","\u200b","$","6.95","\u200b"],["Diluted earnings per common share","\u200b","\u200b","6.62","\u200b","\u200b","\u200b","5.93","\u200b","\u200b","\u200b","6.91","\u200b"],["\u200b","\u200b","\u200b","\u200b","","\u200b","\u200b","\u200b","\u200b","\u200b","","\u200b","\u200b"]]
[[/GREPCENT_TABLE]]

[[GREPCENT_TABLE]]
[["(1)","Determined by subtracting the average cost of total interest-bearing liabilities from the average yield on total interest-earning assets."]]
[[/GREPCENT_TABLE]]

[[GREPCENT_TABLE]]
[["(2)","Determined by dividing net interest income by total average interest-earning assets."]]
[[/GREPCENT_TABLE]]

Discussion of Financial Condition

The Company had total assets of $8.3 billion at December 31, 2025, an increase of 13.1% from December 31, 2024.

Total cash and cash equivalents were $393.6 million at December 31, 2025, an increase of $193.3 million, or 96.5%, from December 31, 2024. The increase was due primarily to an increase of $1.4 billion in deposits, partially offset by an increase in the loan book of $776.2 million and a decrease of $450.0 million in wholesale funding.

Investments

Total securities were $941.2 million at December 31, 2025, an increase of 2.8% from December 31, 2024. The change reflects $199.1 million of purchases of securities, partially offset by $179.8 million in paydowns and maturities of securities, and $18.4 million in sales of AFS securities.

The following table sets forth the stated maturities and weighted average yields of investment securities, excluding equity securities, at December 31, 2025. The table does not include the effect of prepayments or scheduled principal amortization. The weighted average yield for each group o

[Excerpt truncated for page length; the complete text is on the linked full-MD&A page.]

Read the full FY 2025 MD&A: /company/MCB/mda/fy2025/
All MD&A years: /company/MCB/mda/


## MD&A history

Prior-year 10-K MD&A spans are extracted from SEC filings with the same bounded parser used for the latest filing. Each year's full verbatim text is on its own sub-page.

- [FY 2024 MD&A](/company/MCB/mda/fy2024/): filed 2025-02-28; accession 0001558370-25-001884 (https://www.sec.gov/Archives/edgar/data/1476034/000155837025001884/mcb-20241231x10k.htm)
- [FY 2023 MD&A](/company/MCB/mda/fy2023/): filed 2024-02-28; accession 0001558370-24-001997 (https://www.sec.gov/Archives/edgar/data/1476034/000155837024001997/mcb-20231231x10k.htm)
- [FY 2022 MD&A](/company/MCB/mda/fy2022/): filed 2023-02-28; accession 0001558370-23-002263 (https://www.sec.gov/Archives/edgar/data/1476034/000155837023002263/mcb-20221231x10k.htm)
- [FY 2021 MD&A](/company/MCB/mda/fy2021/): filed 2022-03-10; accession 0001558370-22-003202 (https://www.sec.gov/Archives/edgar/data/1476034/000155837022003202/mcb-20211231x10k.htm)




## Macro cross-references

Indicators mapped to this company's SIC classification (industry 6022 State Commercial Banks) by grepcent's deterministic macro-sector crosswalk. A navigational mapping, not a statistical or causal claim.

- [FEDFUNDS](/indicator/FEDFUNDS/): Federal Funds Effective Rate
- [DFEDTARU](/indicator/DFEDTARU/): Federal Funds Target Range - Upper Limit
- [DGS2](/indicator/DGS2/): Market Yield on U.S. Treasury Securities at 2-Year Constant Maturity
- [DGS10](/indicator/DGS10/): Market Yield on U.S. Treasury Securities at 10-Year Constant Maturity
- [T10Y2Y](/indicator/T10Y2Y/): 10-Year Treasury Constant Maturity Minus 2-Year Treasury Constant Maturity

Macro-to-micro threads including this sector: [Interest rates & the Fed](/thread/interest-rates-fed/), [Money & trade](/thread/money-trade/), [Consumer & credit](/thread/consumer-credit/), [Government finances](/thread/government-finances/), [Sector employment](/thread/sector-employment/).

All macro indicators: /indicators/


## For LLMs & downloads

Markdown twin: /company/MCB.md · JSON record: /company/MCB.json · verified financials: /company/MCB/financials.json / /company/MCB/financials.csv · machine TOC for the whole site: /llms.txt